Work

Effect of first-line pembrolizumab treatment in individuals with advanced non-small cell lung cancer and poor performance status.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.15_suppl.e18796

Authors: Rajwanth Veluswamy, Jiayi Ji, Liangyuan Hu, Xiaoliang Wang, Cardinale B. Smith, Minal Kale

Institutions: Icahn School of Medicine at Mount Sinai, Flatiron Health (United States)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3170290359

Cites:

Cited by:

Related to: 10